Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New ways of treating Alzheimer’s

01.11.2011
Several potential drugs for the treatment of Alzheimer’s have worked well on mice – but none of them on humans. A leading researcher from the Sahlgrenska Academy at the University of Gothenburg, Sweden, is now launching brand new methods for diagnosing Alzheimer’s and monitoring treatment.
Research advances in recent years have given us a detailed knowledge of the molecular mechanisms behind Alzheimer’s disease. The spotlight has fallen on beta amyloid, a peptide formed from a special protein in the brain. The prevailing hypothesis is that the protein clumps together into plaques, which damage the brain’s nerve cells and causes the characteristic symptoms of Alzheimer’s.

The amyloid theory has spawned a large number of potential drugs which attempt to delay the development of the disease by slowing down the formation of, or even clearing, plaques. However, several major clinical trials have shown that this type of medication is not at all effective.

Kaj Blennow, a professor at the University of Gothenburg’s Sahlgrenska Academy and one of the world’s leading dementia researchers, is now taking research into new Alzheimer’s medication in a brand new direction.
“It’s important that we constantly question research results, including in Alzheimer’s research,” says Blennow. “And to do this we have to come up with new analytical methods.”

Blennow and his research colleagues believe that the solution lies in being able to test different drugs directly on living patients instead of on mice as has been the case to date.
“The mouse models currently being used have a very tenuous link to the most common form of Alzheimer’s,” says Blennow. “This is particularly obvious when new drug candidates are tested on real people – we have now identified over 100 molecules that reduce the formation of plaques in mice with Alzheimer’s, but unfortunately none have led to a single drug that slows down the illness in humans.”

Blennow and his research colleagues at the Clinical Neurochemistry Laboratory are trying instead to come up with new analytical methods that use biomarkers to monitor biochemical changes in patients with Alzheimer’s. It is hoped that the biomarkers can be used both to make an accurate and early diagnosis and to establish and monitor the effects of new drugs.

“Our studies on patients with Alzheimer’s and other age-related disorders would suggest that beta-amyloid is perhaps not the direct cause of the illness, but instead the brain’s response to different types of stress,” says Blennow. “This could completely change the way we view the illness and could play a crucial role in future treatments.”

ALZHEIMER’S DISEASE
With more than 100,000 people affected in Sweden, Alzheimer’s is one of our most common diseases. Caused by changes in the brain’s nerve cells, the disease predominantly affects the memory and often leads to an early death. Alzheimer’s results in not only considerable suffering for patients and their families, but also enormous costs to society.
For more information, please contact: Kaj Blennow
Tel: +46 (0)31 343 1791, mobile: +46 (0)761 073 835
E-mail: kaj.blennow@neuro.gu.se

Helena Aaberg | idw
Further information:
http://www.gu.se

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>